Romano Brothers & Co’s Rentokil RTO Stock Holding History

Romano Brothers & Co’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,237	Closed	-$38.1K	–	834
2022 Q4	$38.1K	Buy	+1,237	New	+$38.4K	0.01%	511

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Romano Brothers & Co's RTO Position: Q1 2023 in Review

Romano Brothers & Co sold out of Rentokil (RTO) in Q1 2023, closing a stake of 1,237 shares — an estimated $38.1K sold.

Romano Brothers & Co first reported a position in RTO in Q4 2022 and held it in 1 quarter. The position peaked at $38.1K in Q4 2022. 191 funds tracked by Wall St. Rank hold RTO as of Q1 2023.

Romano Brothers & Co reported no remaining Rentokil position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 1,237 Rentokil shares in Q1 2023, an estimated $38.1K.
Romano Brothers & Co first reported a position in Rentokil in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Rentokil position peaked at $38.1K in Q4 2022.
191 funds tracked by Wall St. Rank held Rentokil as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.